CN105535300A - Drug for treating hypertensive disease - Google Patents
Drug for treating hypertensive disease Download PDFInfo
- Publication number
- CN105535300A CN105535300A CN201610033786.6A CN201610033786A CN105535300A CN 105535300 A CN105535300 A CN 105535300A CN 201610033786 A CN201610033786 A CN 201610033786A CN 105535300 A CN105535300 A CN 105535300A
- Authority
- CN
- China
- Prior art keywords
- parts
- hypertension
- fructus
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating a hypertensive disease. The drug is prepared from the following raw medicinal materials in parts by weight: 11 parts of poria with hostwood, 4 parts of felwort, 7 parts of tribulus terrestris, 9 parts of rosa laevigata michx, 2 parts of asarum, 8 parts of rhizoma alismatis, 9 parts of radix pseudostellariae, 7 parts of fructus viticis and 5 parts of ligusticum sinensis. According to the drug provided by the invention, the poria with hostwood is used for calming nerves, pacifying mind, and inducing diuresis; the felwort is used for clearing away heat, eliminating dampness, and purging liver and gallbladder fire; the fructus viticis is used for calming liver, resolving depression, promoting blood circulation and dispelling wind; the rosa laevigata michx is used for securing essence, reducing urination, relieving diarrhea and stopping diarrhea; the asarum is used for expelling wind, removing cold, resuscitating, relieving pain, and warming lung to reduce watery phlegm; the rhizoma alismatis is used for inducing diuresis and eliminating dampness and heat; the radix pseudostellariae is used for replenishing Qi to invigorate spleen, promoting the production of body fluid and moistening lung; the fructus viticis is used for dispelling wind and heat and clearing away dizziness; the ligusticum sinensis is used for expelling wind, clearing away cold, and relieving dampness and pain. After combined use, all the medicines achieve the effects of regulating and invigorating Yin-Yang, nourishing liver and kidney, and activating Yang and resuscitating. A clinical experiment proves that the drug provided by the invention can safely and effectively treat the hypertensive disease.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of hypertension.
Background technology
Hypertension refers to a kind of syndrome caused by systemic arterial blood pressure raises, and belongs to essential hypertension, accounts for the overwhelming majority of hypertension incidence number.Be secondary to some disease and the hypertension that causes, belong to secondary hypertension, also known as symptomatic hypertension.Hypertension exceedes arm's length standard with blood pressure, and common dizziness, headache, the disease such as uncomfortable in chest, weak are main clinical characteristics, can the internal organs organic lesion in various degree such as concurrent heart and brain kidney.The morbidity of hypertension, closely related with the impact of all kinds of factors such as heredity, age, occupation, environment, dietary habit and life habit.Middle-aged and elderly people is main patient groups, and psychentonia and aggravating activities often bring out blood pressure and raise suddenly.The concurrent serious heart and brain renal damage person of hypertension, prognosis mala.Hypertension belongs to the categories such as " dizzy ", " headache " of the traditional Chinese medical science.
Clinical manifestation
Hypertensive symptom varies with each individual.Early stage possibility is asymptomatic or symptom is not obvious, blood pressure only can occur after fatigue, psychentonia, anxious state of mind and raise, and recover normal after rest.Along with the course of disease extends, blood pressure significantly continues to raise, and there will be various symptom gradually.Now be called as benign hypertension.Benign hypertension common clinical symptoms has headache, dizziness, absent minded, hypomnesis, numb limbs and tense tendons, nocturia increase, cardiopalmus, uncomfortable in chest, weak etc.
Severe headache, vomiting, cardiopalmus, the symptom such as dizzy is even there will be when blood pressure is elevated to a certain degree suddenly, obnubilation, tic can be there is time serious, this just belongs to accelerated hypertension and hypertension critical illness, how can there is infringement and the pathological changes of the organs such as the serious heart, brain, kidney in a short time, as apoplexy, heart infarction, renal failure etc.Symptom there is no consistent relation with the level that blood pressure raises.
The clinical manifestation of secondary hypertension is mainly about the sings and symptoms of protopathy, and hypertension is only one of its symptom.The blood pressure of secondary hypertension patient raises can have himself feature, and the hypertension caused by coarctation of aorta can be only limitted to upper limb; The blood pressure that pheochromocytoma causes increases in paroxysmal.
Diagnosis basis
According to the medical history of patient, physical examination and laboratory examination results, can Definite Hypertension.Diagnosis content should comprise: determine blood pressure level and hypertension grading; Without merging other risk factors of cardiovascular diseases; Judge hypertensive reason, clearly with or without secondary hypertension; The target organ situations such as the assessment heart, brain, kidney; Judge that the degree of danger of cardiovascular event appears in patient.
The standard of current domestic hypertensive diagnosis employing Chinese Treatment Guidelines for Hypertension suggestion in 2005:
| Classification | Systolic pressure (mmHg) | Diastolic pressure (mmHg) |
| Normal arterial pressure | <120 | <80 |
| Normal high level | 120～139 | 80～89 |
| Hypertension | ≥140 | ≥90 |
| 1 grade of hypertension (slightly) | 140～159 | 90～99 |
| 2 grades of hypertension (moderate) | 160～179 | 100～109 |
| 3 grades of hypertension (severe) | ≥180 | ≥110 |
| Isolated systolic hypertension | ≥140 | <90 |
When systolic pressure as patient adheres to different ranks separately from diastolic pressure, be then as the criterion with higher grade scale.Isolated systolic hypertension also can be divided into 1,2,3 grade according to systolic pressure level.
Hyperpietic's cardiovascular risk grading standard:
| Other risk factors and medical history | 1 grade | 2 grades | 3 grades |
| Without other risk factors | Low | In | High |
| 1-2 risk factor | In | In | High danger |
| >=3 risk factors or diabetes or target organ damage | High | High | High danger |
| There is complication | High danger | High danger | High danger |
Drug therapy is antihypertensive drug therapy 1., antihypertensive drugs kind, diuretic, beta-blocker, calcium channel blocker, angiotensin converting enzyme inhibitor, hypertensinⅡreceptorretarder.2. therapeutic scheme, most of can separately or conbined usage thiazide diuretic, beta-blocker etc. without complication or complication patient.Treatment should from low dose, progressively ascending-dose.When clinical practice uses, patient's cardiovascular risk factors situation, target organ damage, Complication, efficacy of antihypertensive treatment, untoward reaction etc., all can affect the selection of depressor.2 grades of hyperpietics just can adopt two kinds of antihypertensive drugs therapeutic alliances when starting.3. the treatment of secondary hypertension, mainly for the treatment of protopathy, as the hypertension that pheochromocytoma causes, after tumor resection, blood pressure can be down to normally; Renal vascular hypertension is by interventional therapy nephrectasia tremulous pulse.Can not surgical radical treatment or postoperative blood pressure still high person to protopathy, except other etiotropic treatments of employing, suitable antihypertensive drugs also should be selected to carry out Treatment of Hypertension.4. Traditional Chinese Medical on Treating Hypertension is sick, available traditional Chinese medical herbal treatment, and from many aspects relief of symptoms, effectiveness comparison is desirable.Living habit should be noted, not overworked and anxiety simultaneously.
Medical material involved in the present invention is recorded in " Chinese Pharmacopoeia " all as seen.
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of hypertension, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing hypertension.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of medicine being used for the treatment of hypertension, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Poria cum Radix Pini 11 parts, Radix Gentianae 4 parts, Fructus Atriplicis Sibiricae 7 parts, Fructus Rosae Laevigatae 9 parts, Herba Asari 2 parts, Rhizoma Alismatis 8 parts, Radix Pseudostellariae 9 parts, Fructus Viticis 7 parts, Rhizoma Ligustici 5 parts.
Below in conjunction with theories of Chinese materia medica, beneficial effect of the present invention is described:
Inventor thinks, the cause of disease of hypertension is mainly long-term psychentonia or angry troubled thoughts, causes pathogenic fire derived from stagnation of liver-QI; Addiction to greasy and sweet foods or insobriety, cause the turbid interior life of expectorant; Labor, for excessive or worn with age, causes deficiency of both the liver and kidney, and in a word, the above-mentioned cause of disease makes Liver and kidney imbalance of YIN and YANG, and heresy is sent out as primary disease in clear key.Pathological change is irritability stasis, strongly fragrant fire-transformation of a specified duration, excessive rising of liver-YANG, and Fengyang rises dynamic, above disturbs key clearly, and sees the disease such as headache, dizzy, being irritable and getting angry easily, bitter taste.Eating and drinking without temperance, spleen injury, accumulatively wet raise phlegm, essential resistance of turbid phlegm, clear YANG failing to ascend, turbid YIN failing to descend, breast sun is not opened up, and sees dizziness, the disease such as nose heave, uncomfortable in chest.Labor is for being impairment of the kidney or old deficiency of the kidney, and kidney essense loss, the hepatic and renal YIN deficiency, YIN failing to keep YANG well, empty sun is disturbed, and sees the diseases such as a dull pain, dizzy, tinnitus, the soreness of waist.The course of disease is delayed, and prolonged illness people network, stops in blood stasis, and retardance venation, the blood vessels stasis of blood is stagnant, visible head aching as needle stabbing, or twinge uncomfortable in chest, numb hand and foot, blue-purplish tongue, hesitant pulse.Deficiency of YIN affecting YANG, Liver and kidney deficiency in both YIN and YANG, the moon does not nourish, sun lose temperatureization survey have dizzy, become thin, the disease such as fatigue and weakness, nocturia.If liver-yang is opened cruelly, wind moves with sun, and bleeding resulting from adverse flow of QI horizontally alters meridians, the disturbance mind, hoodwinks key clearly, then see that apoplexy is fainted and heavily demonstrate,prove.Therefore the rule for the treatment of takes dispelling phlegm and eliminating dampness, blood circulation promoting and blood stasis dispelling, suppressing the hyperactive liver and subsiding YANG.
The present invention uses: Poria cum Radix Pini's mind tranquilizing and the heart calming, diuretic; Radix Gentianae heat clearing and damp drying, eliminating pathogen in the liver gallbladder fire; Fructus Atriplicis Sibiricae suppressing the hyperactive liver resolving depression, promoting blood circulation by removing wind; Fructus Rosae Laevigatae controlling nocturnal emission with astringent drugs reducing urination, relieving diarrhea with astringents; Herba Asari expelling wind and cold, understand things pain-stopping, warming the lung to resolve fluid-retention; Rhizoma Alismatis diuresis, clearing away damp-heat; Radix Pseudostellariae replenishing QI to invigorate the spleen, promoting the production of body fluid for nourishing the lung; Fructus Viticis dispelling wind and heat pathogens, the clear sharp head; Rhizoma Ligustici expelling wind and cold, removing damp and stopping pain.All medicines share, and reach effect of adjusting and runing yang, nourishing the liver and kidney, activating YANG to wake up the patient from unconciousness.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects 87 routine patients with hypertension between in March ,-2015 in January, 2013 altogether.Be divided at random: treatment group 43 example, matched group 44 example.Wherein treatment group man 18 example, female 25 example, 36 ~ 74 years old age, the course of disease 1 year ~ 7 years; Matched group man 19 example, female 25 example, between 34 ~ 78 years old age, the course of disease 1 year ~ 8 years.The data there was no significant differences such as two groups of sexes, age, courses of disease, have comparability.
Diagnostic criteria
Determine according to World Health Organization (WHO) (WHO) standard of revising in 1999: I level hypertension (mild hypertension) systolic pressure: 18.67 ~ 21.20kPa (140 ~ 159mmHg) diastolic pressure: 12.00 ~ 13.20kPa (90 ~ 99mmHg) borderline hypertension: systolic pressure: 18.67 ~ 19.87kPa (140 ~ 149mmHg) diastolic pressure: 12.00 ~ 12.53kPa (90 ~ 94mmHg) II grade of hypertension (moderate hypertension) systolic pressure: 21.33 ~ 23.87kPa (160 ~ 179mmHg) diastolic pressure: 13.33 ~ 14.53kPa (100 ~ 109mmHg) III grade of hypertension (severe hypertension) systolic pressure >=24.00kPa (180mmHg) diastolic pressure >=14.67kPa (110mmHg).
1. inclusive criteria meets diagnostic criteria; 2. 18 ~ 80 years old age; 3. compliance is good; 4. Informed Consent Form is signed voluntarily.
1. exclusion standard merges other serious diseases of cardiovascular system patient; 2. severe cardiac, lung, liver, renal disease patient is suffered from; 3. spiritedness systemic disease, can not partner treatment person; 4. through the patient of other drug treatment after falling ill.
2, Therapeutic Method
The capsule that the oral the present invention for the treatment of group obtains according to specific embodiment 3, every day 3 times.Treat 1 month.
The oral Amlodipine Besylate Tablet of matched group, each 5mg, every day 1 time.Treat 1 month.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
1. effective: diastolic pressure decline 10mmHg is also down to normal, or decline 20mmHg or more.
2. effective: diastolic pressure declines and do not reach 10mmHg but be down to normal, or decline l0 ~ 19mmHg.
3. invalid: not reach above-mentioned standard.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
| Group | n | Effective | Effectively | Invalid | Total effective rate (%) | Obvious adverse reaction example |
| Treatment group | 43 | 21 | 15 | 7 | 84％ | 0 |
| Matched group | 44 | 8 | 25 | 11 | 75％ | 0 |
Visible, the medicine that the present invention obtains can safe and effective Hypertension, and cure rate is high.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Poria cum Radix Pini 11 grams, Radix Gentianae 4 grams, Fructus Atriplicis Sibiricae 7 grams, Fructus Rosae Laevigatae 9 grams, Herba Asari 2 grams, Rhizoma Alismatis 8 grams, Radix Pseudostellariae 9 grams, Fructus Viticis 7 grams, Rhizoma Ligustici 5 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of hypertension.Oral, daily once.
Embodiment 2
Take: Poria cum Radix Pini 11 grams, Radix Gentianae 4 grams, Fructus Atriplicis Sibiricae 7 grams, Fructus Rosae Laevigatae 9 grams, Herba Asari 2 grams, Rhizoma Alismatis 8 grams, Radix Pseudostellariae 9 grams, Fructus Viticis 7 grams, Rhizoma Ligustici 5 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of hypertension.Oral, every bu is taken for twice sooner or later.
Embodiment 3
Take: Poria cum Radix Pini 11 grams, Radix Gentianae 4 grams, Fructus Atriplicis Sibiricae 7 grams, Fructus Rosae Laevigatae 9 grams, Herba Asari 2 grams, Rhizoma Alismatis 8 grams, Radix Pseudostellariae 9 grams, Fructus Viticis 7 grams, Rhizoma Ligustici 5 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of hypertension.Oral, every bu morning, noon and afternoon take for three times.
Claims (4)
1. one kind is used for the treatment of the medicine of hypertension, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Poria cum Radix Pini 11 parts, Radix Gentianae 4 parts, Fructus Atriplicis Sibiricae 7 parts, Fructus Rosae Laevigatae 9 parts, Herba Asari 2 parts, Rhizoma Alismatis 8 parts, Radix Pseudostellariae 9 parts, Fructus Viticis 7 parts, Rhizoma Ligustici 5 parts.
2. a kind of medicine being used for the treatment of hypertension as claimed in claim 1, it is characterized in that, its preparation method is: take: Poria cum Radix Pini 11 parts, Radix Gentianae 4 parts, Fructus Atriplicis Sibiricae 7 parts, Fructus Rosae Laevigatae 9 parts, Herba Asari 2 parts, Rhizoma Alismatis 8 parts, Radix Pseudostellariae 9 parts, Fructus Viticis 7 parts, Rhizoma Ligustici 5 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. a kind of medicine being used for the treatment of hypertension as claimed in claim 1, it is characterized in that, its preparation method is: take: Poria cum Radix Pini 11 parts, Radix Gentianae 4 parts, Fructus Atriplicis Sibiricae 7 parts, Fructus Rosae Laevigatae 9 parts, Herba Asari 2 parts, Rhizoma Alismatis 8 parts, Radix Pseudostellariae 9 parts, Fructus Viticis 7 parts, Rhizoma Ligustici 5 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. a kind of medicine being used for the treatment of hypertension as claimed in claim 1, it is characterized in that, its preparation method is: take: Poria cum Radix Pini 11 parts, Radix Gentianae 4 parts, Fructus Atriplicis Sibiricae 7 parts, Fructus Rosae Laevigatae 9 parts, Herba Asari 2 parts, Rhizoma Alismatis 8 parts, Radix Pseudostellariae 9 parts, Fructus Viticis 7 parts, Rhizoma Ligustici 5 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610033786.6A CN105535300A (en) | 2016-01-19 | 2016-01-19 | Drug for treating hypertensive disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610033786.6A CN105535300A (en) | 2016-01-19 | 2016-01-19 | Drug for treating hypertensive disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105535300A true CN105535300A (en) | 2016-05-04 |
Family
ID=55815211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610033786.6A Withdrawn CN105535300A (en) | 2016-01-19 | 2016-01-19 | Drug for treating hypertensive disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105535300A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342477A (en) * | 2000-09-11 | 2002-04-03 | 段世荣 | Quick-acting hypertension capsule |
| CN101502352A (en) * | 2009-01-20 | 2009-08-12 | 顾一平 | Multifunctional shoe pad and preparation method thereof |
| CN101579492A (en) * | 2009-03-23 | 2009-11-18 | 路正平 | Medicine for treating high blood pressure and preparation method thereof |
| CN101601794A (en) * | 2008-06-13 | 2009-12-16 | 任淑君 | The hypoglycemic and thirst-relieving Chinese medicine preparation |
| CN101664519A (en) * | 2009-09-04 | 2010-03-10 | 吴小娟 | Medicament for treating hypertension and preparation method thereof |
| CN102784273A (en) * | 2012-08-01 | 2012-11-21 | 王淑芳 | Method for preparing traditional Chinese medicine for treating insomnia caused by high blood pressure |
| CN104758644A (en) * | 2015-03-16 | 2015-07-08 | 关捷 | Traditional Chinese medicine composition for treating hypertension in the type of hyperactivity of liver yang |
| CN104906407A (en) * | 2015-05-06 | 2015-09-16 | 金胜文 | Drug for preparing drug pillow, drug pillow and preparation method of drug pillow |
| CN104906507A (en) * | 2015-06-09 | 2015-09-16 | 张保全 | Traditional Chinese medicine combination for lowering blood pressure and toning physical fitness |
| CN105056124A (en) * | 2015-08-13 | 2015-11-18 | 申六 | Medicine for treating hypertension and diabetes |
-
2016
- 2016-01-19 CN CN201610033786.6A patent/CN105535300A/en not_active Withdrawn
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342477A (en) * | 2000-09-11 | 2002-04-03 | 段世荣 | Quick-acting hypertension capsule |
| CN101601794A (en) * | 2008-06-13 | 2009-12-16 | 任淑君 | The hypoglycemic and thirst-relieving Chinese medicine preparation |
| CN101502352A (en) * | 2009-01-20 | 2009-08-12 | 顾一平 | Multifunctional shoe pad and preparation method thereof |
| CN101579492A (en) * | 2009-03-23 | 2009-11-18 | 路正平 | Medicine for treating high blood pressure and preparation method thereof |
| CN101664519A (en) * | 2009-09-04 | 2010-03-10 | 吴小娟 | Medicament for treating hypertension and preparation method thereof |
| CN102784273A (en) * | 2012-08-01 | 2012-11-21 | 王淑芳 | Method for preparing traditional Chinese medicine for treating insomnia caused by high blood pressure |
| CN104758644A (en) * | 2015-03-16 | 2015-07-08 | 关捷 | Traditional Chinese medicine composition for treating hypertension in the type of hyperactivity of liver yang |
| CN104906407A (en) * | 2015-05-06 | 2015-09-16 | 金胜文 | Drug for preparing drug pillow, drug pillow and preparation method of drug pillow |
| CN104906507A (en) * | 2015-06-09 | 2015-09-16 | 张保全 | Traditional Chinese medicine combination for lowering blood pressure and toning physical fitness |
| CN105056124A (en) * | 2015-08-13 | 2015-11-18 | 申六 | Medicine for treating hypertension and diabetes |
Non-Patent Citations (1)
| Title |
|---|
| 王守富等: ""从五脏相关论治高血压病"", 《新中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205107A (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103202879B (en) | Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof | |
| CN101264291A (en) | Medicaments assembly for treating scapulohumeral periarthritis and preparation thereof | |
| CN105030919A (en) | Medicinal composition for treating cerebral hemorrhage | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN103751591A (en) | Preparation method of traditional Chinese medicine for treating hyperlipemia caused by deficiency of both yin and yang | |
| CN103751679A (en) | Preparation method of traditional Chinese medicine for treating liver/kidney-yin-deficiency-type hyperlipemia | |
| CN103479763B (en) | Traditional Chinese medicine composition for treating borderline hypertension and preparation method thereof | |
| CN103055122B (en) | The medicine and preparation method thereof of restenosis after prevention percutaneous transluminal coronary stent implantation | |
| CN103920102A (en) | Traditional Chinese medicine for treating primary hypotension | |
| CN102793903B (en) | Preparation method of Chinese medicament for treating kidney-yang deficiency type acute glomerulonephritis | |
| CN103798472B (en) | A kind of health protection tea and health care's preparation | |
| CN105535300A (en) | Drug for treating hypertensive disease | |
| CN101658566B (en) | Chinese medicinal composition for treating hypertension | |
| CN101085330A (en) | Oral administration traditional Chinese medicine composition for treating hyperlipoidemia | |
| CN101066391B (en) | A pharmaceutical composition for treating hypertension | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
| CN104306649A (en) | Medicament for treating herpes zoster | |
| CN101524482A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN102631648A (en) | Chinese patent medicine for treating acute urticaria | |
| CN107693621A (en) | Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment | |
| CN107980988A (en) | Speen-kidney dificiency health preserving tea and preparation method thereof | |
| CN103751678A (en) | Preparation method of traditional Chinese medicine for treating spleen/kidney-yang-deficiency-type hyperlipemia | |
| CN103169888A (en) | Traditional Chinese medicine composition for treating hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160504 |
|
| WW01 | Invention patent application withdrawn after publication |